LumiThera Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $178M

LumiThera General Information

Description

Developer of medical devices intended to prevent vision loss and blindness. The company's offerings include photobiomodulation treatments using non-invasive light-emitting diodes for acute and chronic ocular diseases and disorders, improving visual acuity and contrast sensitivity and reducing central drusen volume, enabling healthcare providers to provide better treatment for dry age-related muscular degeneration.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 19578 10th Avenue North East
  • Suite 200
  • Poulsbo, WA 98370
  • United States
+1 (844)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Parent Company
Corporate Office
  • 19578 10th Avenue North East
  • Suite 200
  • Poulsbo, WA 98370
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LumiThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 02-Sep-2025 $178M Completed Clinical Trials - General
13. Later Stage VC (Series C1) 26-Feb-2025 Completed Clinical Trials - General
12. Later Stage VC (Series C1) 01-May-2023 Completed Clinical Trials - General
11. Later Stage VC (Series C1) 19-Oct-2021 Completed Clinical Trials - General
10. Secondary Transaction - Private Completed Clinical Trials - General
9. Grant 03-Sep-2020 Completed Clinical Trials - General
8. Later Stage VC (Series C) 01-Sep-2020 Completed Clinical Trials - General
7. Grant 26-Feb-2019 Completed Clinical Trials - General
6. Angel (individual) 01-Jan-2019 $9.7M Completed Clinical Trials - General
5. Early Stage VC (Series B) 13-Jul-2017 $5.5M $9.7M Completed Clinical Trials - General
To view LumiThera’s complete valuation and funding history, request access »

LumiThera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-1
Series C
Series B 3,600,000 $0.001000 6% $1.54 $1.54 1x $1.54 11.55%
Series A 3,500,000 $0.001000 6% $1.11 $1.11 1x $1.11 11.23%
To view LumiThera’s complete cap table history, request access »

LumiThera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices intended to prevent vision loss and blindness. The company's offerings include photobiomodu
Other Devices and Supplies
Poulsbo, WA
21 As of 2026

San Clemente, CA
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LumiThera Competitors (8)

One of LumiThera’s 8 competitors is LIGHTMED, a Corporation company based in San Clemente, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LIGHTMED Corporation San Clemente, CA
Konan Medical Corporation Irvine, CA
MuReva Phototherapy Venture Capital-Backed Brecksville, OH
NeoMedLight Venture Capital-Backed Villeurbanne, France
Ceribell Formerly VC-backed Sunnyvale, CA
You’re viewing 5 of 8 competitors. Get the full list »

LumiThera Patents

LumiThera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210059858-A1 Methods for preventing and treating ocular disease Inactive 04-Sep-2019
WO-2019090159-A1 Methods for treating ocular disease Inactive 02-Nov-2017
JP-2017530774-A Multi-wavelength phototherapy apparatus, system and method for non-invasive treatment of damaged or diseased tissue Active 09-Sep-2014
JP-2026086468-A Multi-wavelength phototherapy device, system and method for non-invasive treatment of damaged or diseased tissue Pending 09-Sep-2014
ES-2837061-T3 Multi-wavelength phototherapy devices for non-invasive treatment of diseased or damaged tissue Active 09-Sep-2014 A61F9/0079
To view LumiThera’s complete patent history, request access »

LumiThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LumiThera Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures Capital Venture Capital Minority
Angels + Life.Sci Investors Network Angel Group Minority
Ark Canada Investment Group Family Office Minority
Celeste Management Family Office Minority
Denniston Family Office Family Office Minority
You’re viewing 5 of 20 investors. Get the full list »

LumiThera Acquisitions (2)

LumiThera’s most recent deal was a Merger/Acquisition with MacuLogix. The deal was made on 26-Jul-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MacuLogix 26-Jul-2022 Merger/Acquisition Diagnostic Equipment
Diopsys 05-Mar-2022 Merger/Acquisition Diagnostic Equipment
To view LumiThera’s complete acquisitions history, request access »

LumiThera FAQs

  • When was LumiThera founded?

    LumiThera was founded in 2013.

  • Where is LumiThera headquartered?

    LumiThera is headquartered in Poulsbo, WA.

  • What is the size of LumiThera?

    LumiThera has 21 total employees.

  • What industry is LumiThera in?

    LumiThera’s primary industry is Other Devices and Supplies.

  • Is LumiThera a private or public company?

    LumiThera is a Private company.

  • What is the current valuation of LumiThera?

    The current valuation of LumiThera is .

  • What is LumiThera’s current revenue?

    The current revenue for LumiThera is .

  • How much funding has LumiThera raised over time?

    LumiThera has raised $39.3M.

  • Who are LumiThera’s investors?

    3E Bioventures Capital, Angels + Life.Sci Investors Network, Ark Canada Investment Group, Celeste Management, and Denniston Family Office are 5 of 20 investors who have invested in LumiThera.

  • Who are LumiThera’s competitors?

    LIGHTMED, Konan Medical, MuReva Phototherapy, NeoMedLight, and Ceribell are some of the 8 competitors of LumiThera.

  • When was LumiThera acquired?

    LumiThera was acquired on 02-Sep-2025.

  • Who acquired LumiThera?

    LumiThera was acquired by Alcon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process